tm logo

Monitor this mark

View On USPTO

RHOFADE
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 30 Jul 2024

Last Applicant/ Owned by

MAYNE PHARMA LLC

#401

RALEIGH

NC

27609

Serial Number

86306966 filed on 11th Jun 2014

Registration Number

5232934 registered on 27th Jun 2017

in the Principal Register

Correspondent Address

Monica Riva Talley

Sterne, Kessler, Goldstein & Fox P.L.L.C.

1101 K Street, N.W.

Washington, DC 20005

US

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

RHOFADE

Pharmaceutical preparation for the treatment of erythema associated with rosacea

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparation for the treatment of erythema associated with rosacea

First Use Date in General

21st Apr 2017

First Use Date in Commerce

21st Apr 2017

Mark Details

Serial Number

No 86306966

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 6219.0010000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
30th Jul 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
30th Jul 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
30th Jul 2024POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
10th Jul 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10th Jul 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 15
03rd Jan 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
27th Dec 2023TEAS SECTION 8 & 15 RECEIVED
02th Nov 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
02th Nov 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
02th Nov 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED